Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMC 230283)

Published in J Virol on December 01, 1997

Authors

E S Withers-Ward1, J B Jowett, S A Stewart, Y M Xie, A Garfinkel, Y Shibagaki, S A Chow, N Shah, F Hanaoka, D G Sawitz, R W Armstrong, L M Souza, I S Chen

Author Affiliations

1: Department of Microbiology and Immunology, UCLA School of Medicine, Los Angeles, California 90095-1678, USA.

Articles citing this

Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4. EMBO J (2002) 3.12

Conserved plant genes with similarity to mammalian de novo DNA methyltransferases. Proc Natl Acad Sci U S A (2000) 2.72

Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines. J Virol (2003) 2.46

Ubiquitin-associated (UBA) domains in Rad23 bind ubiquitin and promote inhibition of multi-ubiquitin chain assembly. EMBO Rep (2001) 2.10

Temporal gene regulation during HIV-1 infection of human CD4+ T cells. Genome Res (2001) 1.83

The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate. J Virol (2000) 1.79

Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. J Virol (1998) 1.70

The Vpr protein from HIV-1: distinct roles along the viral life cycle. Retrovirology (2005) 1.67

Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation. J Virol (2000) 1.61

The ubiquitin-associated domain of hPLIC-2 interacts with the proteasome. Mol Biol Cell (2003) 1.32

HIV-1 Vpr: mechanisms of G2 arrest and apoptosis. Exp Mol Pathol (2008) 1.29

Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages. Retrovirology (2007) 1.27

Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin-associated domain-containing protein to promote protein degradation. Mol Cell Biol (2004) 1.10

Retracted Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A. EMBO J (2000) 1.08

Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of wee1, ppa2, and rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr. J Virol (2000) 1.06

Phosphorylation of human immunodeficiency virus type 1 Vpr regulates cell cycle arrest. J Virol (2000) 1.05

Yeast UBL-UBA proteins have partially redundant functions in cell cycle control. Cell Div (2006) 1.01

A carboxy-terminally truncated form of the human immunodeficiency virus type 1 Vpr protein induces apoptosis via G(1) cell cycle arrest. J Virol (2000) 1.01

Structural requirements for the ubiquitin-associated domain of the mRNA export factor Mex67 to bind its specific targets, the transcription elongation THO complex component Hpr1 and nucleoporin FXFG repeats. J Biol Chem (2009) 0.96

Novel HIV-1 knockdown targets identified by an enriched kinases/phosphatases shRNA library using a long-term iterative screen in Jurkat T-cells. PLoS One (2010) 0.91

Investigating the importance of proteasome-interaction for Rad23 function. Curr Genet (2002) 0.88

The presence of human immunodeficiency virus type 1 Vpr correlates with a decrease in the frequency of mutations in a plasmid shuttle vector. J Virol (1999) 0.84

Involvement of rhp23, a Schizosaccharomyces pombe homolog of the human HHR23A and Saccharomyces cerevisiae RAD23 nucleotide excision repair genes, in cell cycle control and protein ubiquitination. Nucleic Acids Res (2002) 0.82

Production of uninfectious human immunodeficiency virus type 1 containing viral protein R fused to a single-chain antibody against viral integrase. J Virol (1998) 0.81

HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome. PLoS One (2010) 0.81

Rad23 interaction with the proteasome is regulated by phosphorylation of its ubiquitin-like (UbL) domain. J Mol Biol (2014) 0.81

Binding of HIV-1 Vpr protein to the human homolog of the yeast DNA repair protein RAD23 (hHR23A) requires its xeroderma pigmentosum complementation group C binding (XPCB) domain as well as the ubiquitin-associated 2 (UBA2) domain. J Biol Chem (2013) 0.78

Improving HIV proteome annotation: new features of BioAfrica HIV Proteomics Resource. Database (Oxford) (2016) 0.75

Articles cited by this

A novel genetic system to detect protein-protein interactions. Nature (1989) 43.83

Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal Biochem (1991) 16.18

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology (1995) 14.30

A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature (1993) 10.36

Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature (1987) 8.87

Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol (1975) 8.68

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci U S A (1994) 7.85

Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol (1995) 7.57

Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci U S A (1993) 6.44

Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev (1993) 5.32

Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. J Virol (1993) 5.30

The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol (1995) 4.42

Identification of HIV-1 vpr product and function. J Acquir Immune Defic Syndr (1990) 4.35

Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol (1990) 4.35

The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J Virol (1995) 4.19

Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J Virol (1993) 4.16

Progression to AIDS in the absence of a gene for vpr or vpx. J Virol (1995) 3.96

Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J Virol (1995) 3.95

Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J Virol (1995) 3.69

The UBA domain: a sequence motif present in multiple enzyme classes of the ubiquitination pathway. Trends Biochem Sci (1996) 3.57

Construction of an improved host strain for two hybrid screening. Nucleic Acids Res (1994) 3.43

Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J Virol (1993) 3.37

Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J (1992) 3.25

Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology (1994) 3.16

Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. EMBO J (1994) 2.94

Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell (1993) 2.90

Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J Virol (1995) 2.88

Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J Virol (1996) 2.86

Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J (1996) 2.84

Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res Hum Retroviruses (1990) 2.67

Reconstitution of yeast nucleotide excision repair with purified Rad proteins, replication protein A, and transcription factor TFIIH. J Biol Chem (1995) 2.65

The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J Virol (1995) 2.64

Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J Virol (1996) 2.33

Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles. J Virol (1994) 2.20

Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1994) 2.00

A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles. J Virol (1995) 1.93

Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J Virol (1996) 1.84

Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein. J Biol Chem (1994) 1.79

HHR23B, a human Rad23 homolog, stimulates XPC protein in nucleotide excision repair in vitro. Mol Cell Biol (1996) 1.63

Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J Biol Chem (1995) 1.58

The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proc Natl Acad Sci U S A (1995) 1.53

Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard. J Virol (1997) 1.52

vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. J Virol (1995) 1.51

A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc Natl Acad Sci U S A (1995) 1.43

Relationships between cdc2 kinase, DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard. Cell Growth Differ (1992) 1.37

XPC and human homologs of RAD23: intracellular localization and relationship to other nucleotide excision repair complexes. Nucleic Acids Res (1996) 1.36

Vpx of simian immunodeficiency virus is localized primarily outside the virus core in mature virions. J Virol (1993) 1.36

The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB. J Mol Biol (1996) 1.29

Yeast DNA repair protein RAD23 promotes complex formation between transcription factor TFIIH and DNA damage recognition factor RAD14. J Biol Chem (1995) 1.26

Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeast Schizosaccharomyces pombe. J Virol (1996) 1.24

Cloning, comparative mapping, and RNA expression of the mouse homologues of the Saccharomyces cerevisiae nucleotide excision repair gene RAD23. Genomics (1996) 1.22

Rad23 is required for transcription-coupled repair and efficient overrall repair in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.14

G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J Biol Chem (1993) 1.13

XPC interacts with both HHR23B and HHR23A in vivo. Mutat Res (1997) 1.04

Articles by these authors

Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med (2000) 19.56

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell (1990) 17.60

Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science (1987) 12.77

Using oligonucleotide probe arrays to access genetic diversity. Biotechniques (1995) 12.18

The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature (1999) 10.87

HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature (1990) 9.72

Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell (1998) 9.41

The Y-family of DNA polymerases. Mol Cell (2001) 6.49

Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J Virol (1992) 5.78

Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nat Med (1996) 5.35

Inhibition of telomerase limits the growth of human cancer cells. Nat Med (1999) 4.96

Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse. Nat Genet (2000) 4.66

The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol (1995) 4.42

Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia (2000) 4.42

Differential expression of the amv gene in human hematopoietic cells. Proc Natl Acad Sci U S A (1982) 4.37

Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc Natl Acad Sci U S A (1985) 4.28

Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science (1986) 3.92

Clearance of HIV infection in a perinatally infected infant. N Engl J Med (1995) 3.76

Mechanisms of accurate translesion synthesis by human DNA polymerase eta. EMBO J (2000) 3.46

Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science (2002) 3.46

The SCID-hu mouse as a model for HIV-1 infection. Nature (1993) 3.43

Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-I and HTLV-II. Science (1984) 3.39

Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity. EMBO J (1999) 3.31

High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature (1990) 3.28

Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations. J Virol (1993) 3.28

Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. J Virol (1991) 3.28

Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science (1988) 3.22

Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev (1991) 3.06

High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Science (1989) 3.00

Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy. Leukemia (2009) 2.94

Low fidelity DNA synthesis by human DNA polymerase-eta. Nature (2000) 2.85

Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J Virol (1997) 2.82

Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood (1992) 2.77

Systolic blood pressure and mortality. Lancet (2000) 2.77

Mechanisms of discordant alternans and induction of reentry in simulated cardiac tissue. Circulation (2000) 2.73

Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method. J Virol (1989) 2.67

Nucleotide sequence analysis of the long terminal repeat of human T-cell leukemia virus type II. Proc Natl Acad Sci U S A (1984) 2.67

Sources of absorption and scattering contrast for near-infrared optical mammography. Acad Radiol (2001) 2.66

Intracellular Ca(2+) dynamics and the stability of ventricular tachycardia. Biophys J (1999) 2.65

A multistep damage recognition mechanism for global genomic nucleotide excision repair. Genes Dev (2001) 2.59

High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J Virol (1996) 2.57

Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. Genes Dev (2001) 2.53

ERCC2: cDNA cloning and molecular characterization of a human nucleotide excision repair gene with high homology to yeast RAD3. EMBO J (1990) 2.53

A comprehensive analysis of DgN(CT) coefficients for pendant-geometry cone-beam breast computed tomography. Med Phys (2004) 2.50

Characterization of reticuloendotheliosis virus strain T DNA and isolation of a novel variant of reticuloendotheliosis virus strain T by molecular cloning. J Virol (1981) 2.49

Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation. Nature (1986) 2.49

The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism. J Virol (1992) 2.49

Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J Virol (1994) 2.45

Cellular sequences are present in the presumptive avian myeloblastosis virus genome. Proc Natl Acad Sci U S A (1980) 2.45

The x gene is essential for HTLV replication. Science (1985) 2.44

Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol (1989) 2.42

Sacral insufficiency fractures: an unsuspected cause of low back pain. Br J Rheumatol (1998) 2.41

Human T-cell leukemia virus type II transforms normal human lymphocytes. Proc Natl Acad Sci U S A (1983) 2.41

Long terminal repeats of human T-cell leukaemia virus II genome determine target cell specificity. Nature (1984) 2.39

Error-prone bypass of certain DNA lesions by the human DNA polymerase kappa. Genes Dev (2000) 2.38

HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. Science (1988) 2.37

Molecular characterization of genome of a novel human T-cell leukaemia virus. Nature (1983) 2.36

Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J Virol (1994) 2.36

Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J Virol (1996) 2.33

Nitrous oxide (Entonox) inhalation and tolerance of transrectal ultrasound guided prostate biopsy: a double-blind randomized controlled study. J Urol (2002) 2.32

Centrosome protein centrin 2/caltractin 1 is part of the xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair. J Biol Chem (2001) 2.32

Interaction of hHR23 with S5a. The ubiquitin-like domain of hHR23 mediates interaction with S5a subunit of 26 S proteasome. J Biol Chem (1999) 2.30

Sulfolobus solfataricus P2 DNA polymerase IV (Dpo4): an archaeal DinB-like DNA polymerase with lesion-bypass properties akin to eukaryotic poleta. Nucleic Acids Res (2001) 2.29

Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest (1992) 2.28

Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet (1988) 2.28

National survey of UK psychiatrists' attitudes to euthanasia. Lancet (1998) 2.27

Establishment of infection by spleen necrosis virus: inhibition in stationary cells and the role of secondary infection. J Virol (1982) 2.26

Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J Virol (1995) 2.22

Model of intracellular calcium cycling in ventricular myocytes. Biophys J (2003) 2.20

Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med (1987) 2.17

Eukaryotic DNA polymerases: proposal for a revised nomenclature. J Biol Chem (2001) 2.15

A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors. Proc Natl Acad Sci U S A (1993) 2.15

Deoxycytidine kinase from calf thymus. Substrate and inhibitor specificity. J Biol Chem (1976) 2.14

Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids. J Nat Prod (1994) 2.12

Binding of host-cell factors to DNA sequences in the long terminal repeat of human T-cell leukemia virus type I: implications for viral gene expression. Proc Natl Acad Sci U S A (1988) 2.12

Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation. J Virol (1990) 2.11

A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection. J Virol (2001) 2.11

Nucleotide sequence of the 3' region of an infectious human T-cell leukemia virus type II genome. Proc Natl Acad Sci U S A (1984) 2.10

Studies of the human c-myb gene and its product in human acute leukemias. Science (1986) 2.10

Role of potentially charged transmembrane residues in targeting proteins for retention and degradation within the endoplasmic reticulum. EMBO J (1991) 2.08

Rapid generation of sequence variation during primary HIV-1 infection. AIDS (1992) 2.08

A brefeldin A-like phenotype is induced by the overexpression of a human ERD-2-like protein, ELP-1. Cell (1992) 2.06

Therapeutic potential of yoga practices in modifying cardiovascular risk profile in middle aged men and women. J Assoc Physicians India (2002) 2.02

The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J (2001) 1.99

A human homologue of the yeast GST1 gene codes for a GTP-binding protein and is expressed in a proliferation-dependent manner in mammalian cells. EMBO J (1989) 1.97

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer (1987) 1.97

Fullerene-like organization of HIV gag-protein shell in virus-like particles produced by recombinant baculovirus. Virology (1994) 1.95

Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia (2010) 1.89

Molecular cloning and biological characterization of a human gene, ERCC2, that corrects the nucleotide excision repair defect in CHO UV5 cells. Mol Cell Biol (1988) 1.89

Functional relation between HTLV-II x and adenovirus E1A proteins in transcriptional activation. Science (1985) 1.87

The xeroderma pigmentosum group C protein complex XPC-HR23B plays an important role in the recruitment of transcription factor IIH to damaged DNA. J Biol Chem (2000) 1.86

Blasticidin S-resistance gene (bsr): a novel selectable marker for mammalian cells. Exp Cell Res (1991) 1.86

Error rate and specificity of human and murine DNA polymerase eta. J Mol Biol (2001) 1.86

Role of papillary muscle in the generation and maintenance of reentry during ventricular tachycardia and fibrillation in isolated swine right ventricle. Circulation (1999) 1.83

Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science (1998) 1.83

Spectroscopy enhances the information content of optical mammography. J Biomed Opt (2002) 1.83